FCM
Farallon Capital Management Portfolio holdings
AUM
$17.3B
1-Year Est. Return
47.36%
This Fund
S&P 500
1 Year Est. Return
+47.36%
AUM
$17.3B
AUM Growth
-$372M
(-2.1%)
Holding
171
Top Buys
| 1 | +$507M | |
| 2 | +$444M | |
| 3 | +$319M | |
| 4 |
Boston Scientific
BSX
|
+$264M |
| 5 |
KKR & Co
KKR
|
+$251M |
Top Sells
| 1 | +$528M | |
| 2 | +$352M | |
| 3 | +$333M | |
| 4 |
Intuit
INTU
|
+$333M |
| 5 |
K
Kellanova
K
|
+$323M |
Sector Composition
| 1 | Healthcare | 49.65% |
| 2 | Technology | 16.89% |
| 3 | Financials | 13% |
| 4 | Consumer Discretionary | 6% |
| 5 | Communication Services | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alphabet (Google) Class C
GOOG
$3.62T
| $247M | 1.43% |
787,040
-333,900
|
|
||
27
McKesson
MCK
$114B
| $245M | 1.42% |
298,900
-28,200
|
|
||
28
Visa
V
$610B
| $244M | 1.41% |
695,910
+96,100
|
|
||
29
New York Times
NYT
$13.3B
| $228M | 1.31% |
3,280,678
-1,705,067
|
|
||
|
DAY
30
DELISTED
Dayforce
DAY
| $202M | 1.17% |
+2,925,000
|
|
||
|
GRAL
31
GRAIL Inc
GRAL
$2.1B
| $201M | 1.16% |
2,342,684
+993,684
|
|
||
|
BITW
32
BITWISE 10 CRYPTO IDX UT
BITW
$944M
| $199M | 1.15% |
+3,385,500
|
|
||
33
CBRE Group
CBRE
$41.7B
| $158M | 0.91% |
983,771
-632,267
|
|
||
34
Agios Pharmaceuticals
AGIO
$1.63B
| $140M | 0.81% |
5,159,505
-621,561
|
|
||
|
CNTA
35
Centessa Pharmaceuticals
CNTA
$3.78B
| $134M | 0.78% |
5,377,068
+1,045,750
|
|
||
|
BBNX
36
Beta Bionics
BBNX
$494M
| $131M | 0.76% |
4,313,920
|
|
||
37
Cardinal Health
CAH
$51.5B
| $118M | 0.68% |
576,000
+323,000
|
|
||
38
Tango Therapeutics
TNGX
$2.08B
| $116M | 0.67% |
13,061,411
+2,304,411
|
|
||
39
Hims & Hers Health
HIMS
$3.64B
| $110M | 0.63% |
3,386,986
-7,359,866
|
|
||
40
iShares Bitcoin Trust
IBIT
$54.3B
| $106M | 0.61% |
2,137,100
-4,855,600
|
|
||
41
Mastercard
MA
$461B
| $98.6M | 0.57% |
172,671
-41,100
|
|
||
|
CDTX
42
DELISTED
Cidara Therapeutics
CDTX
| $84.6M | 0.49% |
382,800
-125,200
|
|
||
43
Tenet Healthcare
THC
$20.8B
| $74M | 0.43% |
372,153
-41,847
|
|
||
44
Welltower
WELL
$140B
| $63.7M | 0.37% |
+343,000
|
|
||
45
TransUnion
TRU
$15.1B
| $57.9M | 0.33% |
675,000
-4,057,075
|
|
||
46
Tyra Biosciences
TYRA
$1.82B
| $54.3M | 0.31% |
2,066,818
+923,000
|
|
||
|
VNET
47
VNET Group
VNET
$2.63B
| $53.2M | 0.31% |
6,285,386
+796,266
|
|
||
|
ABVX
48
Abivax
ABVX
$9.04B
| $52.2M | 0.3% |
387,000
-418,000
|
|
||
49
Enanta Pharmaceuticals
ENTA
$421M
| $43.7M | 0.25% |
2,772,262
+650,000
|
|
||
50
Assembly Biosciences
ASMB
$438M
| $41.8M | 0.24% |
1,227,590
|
|